Background. Effective malaria control programs require continuous monitoring of drug pressure in the field, using molecular markers.
parasite. Some of the digestive food vacuole membrane proteins of the parasite participate in the CQ transportation phenomenon [2] . However, the parasite has developed mechanisms to efflux CQ out of its food vacuole and survive the drug pressure. The exact mechanisms of CQ resistance (CQR) are not very clear, but certain point mutations in the genes encoding 2 of the food vacuole membrane proteins-Plasmodium falciparum CQR transporter protein (Pfcrt), which is encoded by the pfcrt gene, and a P glycoprotein (Pgh-1), which is encoded by the pfmdr1 gene-have been implicated in making the parasite less susceptible to this drug [3] [4] [5] . Indeed, large numbers of field and laboratory studies have corroborated the association between CQR and pfcrt mutations at various codons: C72S/R, M74I/T, N75E/D/K/I, K76T/I/N, I77T, H97Q/L, A144F/T, L148I, L160Y, I194T, and A220S [6] . Although the involvement of pfmdr1 mutations in CQR is being debated, there are reports indicating that the N86Y mutation of this gene in the presence of pfcrt mutations can cause a higher level of CQR [7] [8] [9] . These pfcrt and pfmdr1 mutations are, therefore, suggested to be very useful molecular markers in epidemiological studies for forecasting the spread of CQR [10, 11] .
CQR has reached a very high level in certain parts of the world. This situation has forced several countries to change their antimalarial drug policies. CQR was reported in 1973 in India, and, since then, it has been spreading at a rapid rate [12, 13] . The Indian government had to change its antimalarial drug policy for certain parts of the country where CQR had reached alarming levels. The first line of treatment for malaria in these regions has now been changed to a sulfadoxine-pyrimethamine combination. In India and elsewhere in the world, continuous molecular surveillance is required so that CQR can be monitored in the field, its spread to other areas can be contained, and the local drug policy can be modified accordingly. The present study was conducted to evaluate the pattern of development of mutations in pfcrt and pfmdr1 in Indian isolates at different time points, to assess the level of drug pressure in the field. The results show that a progressive increase in the number of mutations in these genes has led to a shift in the level of CQR during a 2-year period. The rate of mutations in these genes was found to vary from one region to another and was significantly higher in areas with high CQR.
MATERIALS AND METHODS

Parasites.
Patients with fever who were attending malaria clinics in Uttar Pradesh, Madhya Pradesh, Goa, Orissa, Assam, and Andaman and Nicobar were screened by light microscopy for the presence of malarial parasites in their blood. Approximately 50-100 mL of heparinized blood was collected from the P. falciparum-positive patients. Each patient was treated with a standard dosage of CQ (25 mg/kg of body weight over 48 h). Sulfadoxine-pyrimethamine treatment (26.25 mg/kg of body weight) was given only to patients who failed to respond to CQ [14] . Informed consent was obtained from patients before blood collection. The institutional ethical guidelines were followed for blood collection. P. falciparum isolates that had been previously collected, culture adapted, and tested for the MIC of CQ in vitro were also revived and used in the present study [14] .
Polymerase chain reaction (PCR). Genomic DNA was extracted from P. falciparum-infected blood by use of the AccuPrep Genomic DNA Extraction Kit (Bioneer), in accordance with the manufacturer's instructions. The extracted DNA was used for PCR amplification of the region spanning codons 86-184 of pfmdr1 and codons 44-177 and 181-222 of pfcrt.
The primers mdrFor (5 -TGTTGAAAGATGGGTAAAGA-GCAGAAAGAG-3 ) and mdrRev (5 -TACTTTCTTATTACA-TATGACACCACAAACA-3 ) [10] were used for the primary amplification of the 657-bp region of pfmdr1. The primary amplicon was diluted (1:6) and used for the nested PCR. The primers Nestformdr (5 -AAAGATGGTAACCTCAGTATCAA-AGAAGAG-3 ) and Nestrevmdr (5 -GTCAAACGTGCATTTT-TTATTAATGACCAAATA-3 ) were used for the nested PCR [10] . The PCRs were performed in a volume of 25 mL with 0.2 U of Taq DNA polymerase (MBI Fermentas), 0.2 mmol/L each dNTP, 0.5 mmol/L each primer, and 1.5 mmol/L MgCl 2 . Cycling parameters included an initial denaturation at 94ЊC for 10 min, followed by 35 cycles (for primary PCR) or 25 cycles (for nested PCR) of denaturation at 94ЊC for 30 s, annealing at 55ЊC for 45 s, and extension at 72ЊC for 1 min. Final extension was at 72ЊC for 15 min. For amplification of the 1.6-kb fragment of pfcrt, a primary PCR was set up using the primers PFCF (5 -CCGTTAATAATA-AATACAGGC-3 ) and PFCR (5 -CTTTTAAAAATGGAAGGG-TGT-3 ) [15] . The 1.6-kb primary PCR product was diluted 1: 10 and was used for the nested PCRs. The primers used for the nested PCR for the region spanning codons 44-177 were Pf72 (5 -TGTGCTCATGTGTTTAAACTTAT-3 ) and Pr72 (5 -AAAATAGTATACTTACCTATATCT-3 ). The primers for the region spanning codons 181-222 were Pf220 (5 -CTTATACAA-TTATCTCGGAGCAG-3 ) [16] and Pr220 (5 -ATAATAAAAA-CAAAGTTTAAGTGT-3 ). The primary PCR was performed in a volume of 20 mL with 0.2 U of Taq DNA polymerase, 0.2 mmol/L each dNTP, 1 mmol/L each primer, and 1.5 mmol/L MgCl 2 . The reaction was allowed to proceed for 40 cycles after an initial denaturation at 94ЊC for 30 s, annealing at 56ЊC for 1 min, and extension at 60ЊC for 90 s. Final extension was at 60ЊC for 3 min. The nested PCRs for codons 44-177 and 181-222 were performed with a final MgCl 2 concentration of 1 mmol/ L and 1.5 mmol/L and annealing at 52ЊC and 51ЊC, respectively, for 25 cycles. Other nested PCR conditions were the same as those described for the primary PCR.
Nucleotide sequencing. The PCR products were purified from the agarose gel by use of the QIAEX-II Gel Extraction Kit (Qiagen), in accordance with the manufacturer's instructions. From 50 to 250 ng of the gel-purified product was used with the ABI Big Dye Terminator Ready Reaction Kit Version 3.1 (PE Applied Biosystems) for the sequencing PCR. The sequencing PCR was performed in a volume of 20 mL with 1 mL of Terminator Ready Reaction Mix (TRR), 3.2 pmol of genespecific primer, and 0.5ϫ sequencing buffer. Cycling conditions for the sequencing PCR included 25 cycles of denaturation at Sequence analysis. The sequences that were obtained were translated using the Edit Sequence tool (version 5.1; Lasergene). The translated sequences were then aligned using the online multiple sequence alignment tool ClustalW (available at: http: //www.ebi.ac.uk/clustalw).
Statistical analysis. The x 2 test or Fisher's exact test was used to detect significant differences between 2 groups. The Kruskal-Wallis test was applied to compare the MICs of 3 pfcrt genotypes. In the case of a significant result, the multiple comparison test was used to identify pairs of pfcrt genotypes having significantly different MICs. In addition, the Wilcoxon rank sum test was applied to compare 2 pfmdr1 genotypes. was P ! .05 considered to be statistically significant.
RESULTS
Mutation analysis of the pfcrt and pfmdr1 genes. The pfcrt and pfmdr1 genes from a large number of Indian P. falciparum isolates were partially sequenced to study the rate of mutation at various codons that have previously been shown to be associated with CQR-that is, codons 72, 74, 75, 76, 77, 97, 144, 148, 152, 160, 163, 194, and 220 of pfcrt and codons 86 and 184 of pfmdr1 [4, 6, 14, 17] . Although 265 samples provided sequence information for all of the desired pfcrt codons, only 239 isolates were successfully sequenced for codons 86 and 184 of pfmdr1. Mutations were observed in pfcrt at positions 72 (75.84%), 74 (14.30%), 75 (14.33%), 76 (84.15%), and 220 (81.50%), and no mutations were observed at positions 77, 97, 144, 148, 152, 160, 163, or 194. Only 41 isolates (15.47%) were found to contain the wild-type (wt) codon at each of these 13 positions. The remaining samples were found to contain the single-mutation allele CMNKS (0.38%) or CMNTA (2.64%), the double-mutation allele CMNTS (4.91%) or SMNTA (0.38%), the triple-mutation allele SMNTS (61.89%), or the quadruplemutation allele CIETS (12.08%) or CIDTS (2.26%). There were a total of 8 different pfcrt genotypes among these 265 Indian isolates ( figure 1A) . A previous study from India reported that there were only 2 pfcrt genotypes: SMNT and CIET (codons 72, 74-76) [18] .
A mutation at codon 184 (YrF) of pfmdr1 was highly prevalent (99.16%) in the 239 isolates, whereas a mutation at codon figure 1B) ; the NF genotype was prevalent (69.46%), whereas the wt allele (NY) and the singlemutation allele (YY) were very rare.
We also sequenced 45 in vitro culture-adapted and drugtested parasite lines to cover these same codons. Only 27 isolates provided sequence information for all of the pfcrt codons that were targeted, whereas 43 isolates provided information for both of the pfmdr1 codons. Twelve of 27 (44.44%) isolates were wt, and 12 isolates had the mutant pfcrt genotype SMNTS. The remaining isolates (11.11%) were found to contain the pfcrt genotype CIETS. Drug-susceptibility profiles of these genotypes are shown in figure 2A . The median MIC of isolates with mutant pfcrt genotypes was significantly higher ( ) than that P ! .05 of isolates with the wt genotype. Although only 3 isolates had the pfcrt genotype CIETS, they had MICs that were significantly higher than those of isolates with the SMNTS genotype (P ! ). Analysis of the pfmdr1 gene of these parasite lines revealed .05 that a majority of isolates (83.72%) had the NF genotype. Although the pfmdr1 genotype did not have any significant correlation with CQR, isolates with the YF genotype had insignificantly higher median MICs than did isolates with the NF genotype ( figure 2B ).
Temporal increase in pfcrt and pfmdr1 mutations. Samples were divided into 2 groups. Those collected during 2000-2001 were placed into group A, and those collected during 2003-2004 were placed into group B. The rates of mutation for pfcrt are shown in figure 3 . Figure 3A shows that there was a significant increase ( ) in the number of isolates in group B with the P ! .05 M74I and N75E/D mutations. However, there were significantly more isolates in group A with the C72S mutation ( ). The P ! .05 K76T and A220S mutations seemed to have reached the maxi- mum level, and, thus, there was no significant change in the number of isolates with these mutations in the 2 groups (not significant). In group B, significantly more isolates had quadruple pfcrt mutations ( ), and significantly fewer isolates had P ! .05 triple pfcrt mutations ( ) ( figure 3B ). There was an insig-P ! .05 nificant change in the number of isolates with wt pfcrt, single pfcrt mutations, or double pfcrt mutations in these 2 groups. Significantly more isolates in group B had double (YF) pfmdr1 mutations, whereas fewer isolates in this group had single (NF) mutations ( ) ( figure 4 ). This is because the N86Y mutation P ! .05 was found in more isolates in group B ( ) ( figure 4A ). P ! .05 Regional bias in the pfcrt and pfmdr1 mutation rates. The regional distribution of the pfcrt and pfmdr1 genotypes are shown in table 1 and figure 5. Isolates with triple pfcrt mutations (SMNTS) were found in all 5 regions. Indeed, this genotype predominated in all of the regions except Orissa, where the wt genotype was more common. These triple-mutant isolates were present in the highest proportion (100%) in Goa. Isolates from Goa had only a single pfcrt genotype, whereas 6 pfcrt genotypes were observed in Orissa (table 1) . Isolates from Uttar Pradesh, Madhya Pradesh, and Orissa were found to contain wt pfcrt, but this genotype was absent in isolates from Assam, Goa, and Andaman and Nicobar. Similarly, quadruple pfcrt mutations (the CIETS genotype) were found in isolates from Assam, Orissa, and Andaman and Nicobar but not from Uttar Pradesh, Madhya Pradesh, or Goa. Certain pfcrt genotypes were region specific-for example, CMNKS in Uttar Pradesh and SMNTA in Orissa. The N75D mutation was found only in isolates from Orissa and from Andaman and Nicobar. In fact, higher proportions of isolates from Andaman and Nicobar were found to harbor mutations at codons 74 and 75 (the CIETS or CIDTS genotype), compared with isolates from any other place. As a result, more isolates from this region were found to contain quadruple (the CIETS or CIDTS genotype) rather than triple (the SMNTS genotype) mutations (table 1) .
The occurrence of single-or double-mutation pfmdr1 genotypes also varied from one region to another (figure 5). Isolates with the double-mutation pfmdr1 genotype (YF) were most commonly found in Assam, followed by Andaman and Nicobar. Other regions were found to have more isolates with the NF genotype, in varying proportions (figure 5). Indeed, no isolate with the YF genotype was found in Goa, whereas few isolates from Uttar Pradesh and Madhya Pradesh contained this genotype. Proportionately, more isolates from Orissa had the YF genotype than did isolates from Uttar Pradesh or Madhya Pradesh.
Analysis of pfcrt-pfmdr1 2-loci mutations. Analysis of pfcrt-pfmdr1 2-loci mutations was performed with the 234 isolates for which PCR amplification and sequencing was successful at covering all 13 codons of pfcrt and both codons of pfmdr1 that were targeted. A majority of the isolates harbored a mutation in 1 or both genes. There were a total of 15 different 2-loci mutation genotypes among these isolates. Some of these genotypes were found in only 1 or 2 isolates each (table 2). During the 2-year period, 3 new 2-loci mutation genotypes appeared in group B isolates, whereas 2 genotypes disappeared during this period (table 2) . Combined genotype IX was more prevalent (59.09%) in isolates of group A and less prevalent (32.26%) in isolates of group B ( ). However, combined genotypes P ! .05 XIII and XIV were present in fewer isolates in group A than in group B ( ). P ! .05 Analysis of these 2-loci mutation genotypes by region showed that only a single combined genotype-IX-was found in Goa (table 3) . In other regions, 11 combined genotype was found, with Orissa having 9, which was the highest number of combined genotypes. The pattern of prevalence of combined genotypes also varied from one region to another. For example, combined genotype X was more prevalent in Assam, whereas combined genotype IX was more prevalent in Uttar Pradesh, Madhya Pradesh, and Goa. In Orissa, combined genotype II was found in the most isolates. Among isolates from Andaman and Nicobar, no combined genotype was predominant, but combined genotypes X, XIII, and XIV were present at an equal rate (20.00%). Some combined genotypes were region specific-for example, combined genotypes III and VIII in Orissa, combined genotype IV in Uttar Pradesh, combined genotype VII in Andaman and Nicobar, and combined genotype XV in Assam. However, it is possible that these region-specific combined genotypes may have been found in other regions if more samples had been analyzed. Two-loci mutations and expected level of CQR. More isolates in group B had higher total numbers of 2-loci mutations than did isolates in group A ( ). However, group B had P ! .05 fewer isolates with 2-loci single and quadruple mutations (P ! .05) ( figure 6A) . Distribution of the total numbers of 2-loci mutations varied from region to region (figure 6B). The highest number of isolates with 2-loci quintuple mutations was found in Assam ( figure 6B ).
On the basis of the literature and our limited in-vitro CQ susceptibility data, we have attempted to categorize the level of CQR in relation to the number of 2-loci mutations. We have not considered the Y184F mutation to contribute to CQR, because it was present in all of the isolates irrespective of their in-vitro CQ susceptibility level ( figure 2B ). CQ-sensitive isolates were placed into category S, and CQ-resistant isolates were placed into categories defined by increasing orders of resistance (R1, RII, and RIII). Isolates with intermediate mutated gene forms were placed into categories indicating their borderline susceptibility (S/RI, RI/RII, and RII/RIII). Thus, isolates with the CMNKA-NF genotype were considered to be fully susceptible to CQ, whereas isolates with the CMNTA-NF or CMNKA-YF genotype were considered to be at the borderline of reduced CQ susceptibility (S/RI). Isolates with 2 mutations in pfcrt and wt N86 of pfmdr1 (the CMNTS-NF and SMNTA-NF genotypes) were considered to be at the RI level of CQR. Isolates with 3 mutations in pfcrt and wt N86 of pfmdr1 (SMNTS-NF) were categorized as being at the borderline of RI and RII, but isolates with these mutations as well with the N86Y mutation of pfmdr1 (the SMNTS-YF genotype) were considered to be in the RII category. Isolates with quadruple pfcrt mutations at codons 74, 75, 76, and 220 along with wt N86 of pfmdr1 (the CIETS-NF and CIDTS-NF genotypes) were categorized as being at the borderline of RII and RIII (RII/RIII). If these quadruple pfcrt mutations were associated with the N86Y pfmdr1 mutation (the CIETS-YF, CIDTS-YF, and CIETS-YY genotypes), then the isolates were categorized as being in the RIII category. This categorization requires further evidence. However, on the basis of this categorization, the number of isolates at the borderline of RI and RII (RI/RII) decreased significantly ( ) during P ! .05 the 2-year period, whereas the number of isolates with a higher level of CQR (those in the RII/RIII and RIII categories) increased significantly during this period ( ) ( figure 7A ). P ! .05 The occurrence of isolates in these categories varied by region (figure 7B).
DISCUSSION
In an attempt to evaluate drug pressure and the emerging CQR pattern in Indian isolates during a 2-year period, we investigated mutations associated with CQR in the genes that encode the P. falciparum digestive food vacuole membrane proteins Pfcrt and Pgh-1. The number of isolates with quadruple pfcrt and double pfmdr1 mutations increased significantly ( ) P ! .05 during this period, leading to a significant ( ) shift from P ! .05 low to high rates of pfcrt and pfmdr1 2-loci mutations ( figure  6 ). This shift translates into a higher number of isolates with reduced susceptibility to CQ (figure 7). Previous studies have reported that the higher the number of pfcrt mutations, the higher the level of CQR [16, 19] . Indeed, Indian P. falciparum isolates with the CIETS genotype (quadruple mutations) had a higher level of CQR than did isolates with the SMNTS genotype (triple mutations) in our in-vitro experiments ( figure  2A ). This finding also corroborates with the findings of Durrand et al., who reported a higher level of CQR in isolates with the CIET (codons 72, 74-76) pfcrt genotype [20] . Furthermore, Vathsala et al. found that all 4 Indian isolates with this pfcrt genotype were resistant to CQ in vivo [18] .
Eight of our isolates also contained intermediate mutated gene forms (7 isolates with the CMNTA genotype and 1 isolate with the SMNTA genotype), wherein a mutation was found at codon 76, whereas codon 220 had the wt allele ( figure 1A) . A study has shown that isolates with this intermediate form (the CMNTA genotype) show slightly higher IC 50 values for CQ than do isolates with the wt allele [16] . Therefore, it has been proposed that acquisition of CQR is a stepwise process, and that association with additional mutations would give rise to a higher level of CQR.
Our results indicate that K76T could be the first mutation to occur in pfcrt, and it is followed by the A220S mutation. The mutation C72S may occur after the mutation A220S. Mutations in codons 74 and 75 seem to be independent of those in codon 72 and could occur with an increase in drug pressure. Isolates with these mutations (the CIETS genotype) seem to have an advantage over those with the SMNTS genotype, because they could survive the high drug pressure in vitro (figure 2A) [20] . This advantage is also being reflected in the field, because isolates with the CIETS genotype increased in numbers during the 2-year period (figure 3).
It has been proposed that mutations in pfmdr1 may not be sufficient to give rise to CQR but that the N86Y mutation can modulate the drug response [7] [8] [9] [10] . In the present study, 6 of the 7 P. falciparum isolates containing the N86Y mutation in pfmdr1 also showed in-vitro CQR, although a majority of the resistant isolates (23/29) still possessed the wt N86 codon (figure 2B) . Therefore, the N86Y mutation of pfmdr1 in the presence of pfcrt mutations may be involved in modulating the CQ response in Indian isolates. It is difficult to predict the stage at which the N86Y mutation begins to associate with pfcrt mutations, because the N86Y mutation was also found in 2 of our isolates that still had wt pfcrt (wt CMNKA). Nevertheless, there was a trend in which isolates with 2 or more pfcrt mutations could have either codon of pfmdr1-that is, wt N86 or mutated Y86-and no isolate with lower pfcrt mutations (the CMNKS, CMNTA, or SMNTA genotype) was found to contain mutated Y86 of pfmdr1. Thus, the pfmdr1 N86Y mutation may be associating with higher pfcrt mutations to give rise to a higher level of CQR. Isolates from Uttar Pradesh and Madhya Pradesh, where CQR is low, showed a predominance of wt N86. However, the N86Y mutation was predominant in Assam, where CQR is very high. Thus, more isolates from areas where CQR is low (Uttar Pradesh and Madhya Pradesh) had lower numbers of pfcrt and pfmdr1 2-loci mutations, whereas more isolates from areas where CQR is high (such as Assam) had higher numbers of such 2-loci mutations (figure 6). Isolates with more total numbers of 2-loci mutations were increased during the 2-year period, indicating that CQR had increased (figures 6 and 7).
On the basis of the literature and our in-vitro susceptibility results, we predicted the outcome of CQR (figure 7). Our categorization indicates that the number of isolates with a higher level of CQR (those in categories RII/RIII and RIII) increased significantly ( ) during the 2-year period, whereas the P ! .05 number of isolates with a lower level of CQR (those in category RI/RII) decreased significantly ( ) during this period. The P ! .05 expected CQR also varied from region to region and correlated fairly well with the level of CQR that was reported [12, [21] [22] [23] . For example, Assam and Andaman and Nicobar showed the highest CQR, and our categorization also revealed that isolates from these areas have a higher number of 2-loci mutations. However, isolates from Uttar Pradesh and Madhya Pradesh, where the level of CQR remains low, were found to contain lower numbers of 2-loci mutations [12] . Surprisingly, isolates with the pfcrt-pfmdr1 2-loci mutations continued to be high in number in Assam, where CQ had been replaced by sulfadoxine-pyrimethamine as the first line of treatment for malaria. This indicates that drug pressure still continues in this area, because private practitioners may still be prescribing CQ for malaria. Alternatively, mutations in pfcrt had become fixed, and parasites with wt pfcrt were eliminated from this area. This would lead to a situation in which no expansion of wt pfcrt could occur, even in the absence of CQ pressure, which is contrary to the situation in Malawi [24] .
In summary, the present study demonstrates that the CIETS pfcrt genotype is more common in areas with a high level of CQR. Furthermore, the N86Y mutation in pfmdr1 emerges as the number of mutations in pfcrt increases in these areas.
